Get startedLog in
    Picture of Eagle Pharmaceuticals logo

    EGRX — Eagle Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: Eagle Pharmaceuticals Granted Unique J-Code For Byfavo (Remimazolam For Injection) From CMS

    Picture of Eagle Pharmaceuticals logoEagle Pharmaceuticals
    01/05/2023 13:43
    May 1 (Reuters) - Eagle Pharmaceuticals Inc  EGRX.O :
    * EAGLE PHARMACEUTICALS GRANTED UNIQUE J-CODE FOR BYFAVO®¹
(REMIMAZOLAM FOR INJECTION) FROM CMS
    * EAGLE PHARMACEUTICALS INC- J-CODE WILL BE EFFECTIVE ON
JULY 1,
2023

Source text for Eikon:  ID:nGNX1R30nm 
Further company coverage:  EGRX.O 

 ((Reuters.Brief@thomsonreuters.com;))

    Recent news on Eagle Pharmaceuticals

    See all news